Zevra Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
/ 
Frequently asked questions
To buy Zevra Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Zevra Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Zevra Therapeutics Inc. is ZVRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Zevra Therapeutics Inc. has its primary listing on NASDAQ. You can trade Zevra Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Zevra Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Zevra Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Zevra Therapeutics Inc. or others.